E. coli Bacteria Linked To Crohn's Disease
Main Category: GastroIntestinal / GastroenterologyAlso Included In: Infectious Diseases / Bacteria / Viruses; Crohn's / IBD
Article Date: 10 Aug 2007 - 15:00 PDT
| Patient / Public: | ![]() |
4.64 (33 votes) |
| Healthcare Prof: | ![]() |
4.25 (4 votes) |
A team of Cornell University scientists from the College of Veterinary Medicine, Weill Cornell Medical College and the College of Agriculture and Life Sciences have discovered that a novel group of E. coli bacteria -- containing genes similar to those described in uropathogenic and avian pathogenic E. coli and enteropathogenic bacteria such as salmonella, cholera, bubonic plague -- is associated with intestinal inflammation in patients with Crohn's disease in their research paper published by The ISME Journal: Multidisciplinary Journal of Microbial Ecology.
Crohn's disease, an incurable inflammatory disorder of the intestine -- most commonly found in the lower part of the small intestine called the ileum -- affects 1-in-1,000 people in Europe and North America. Thus far, gut bacteria have long been suspected in playing a pivotal role in the development of Crohn's disease, but the specific bacterial characteristics that drive the inflammatory response have remained elusive.
Researchers at Cornell examined possible causes for the disease in patients with Crohn's restricted to the ileum and the colon versus healthy individuals.
"Given that only about 20 percent of fecal bacteria can be cultured, our group adopted a broad culture-independent approach to target specific subgroups of bacteria for quantitative in situ analysis and culture based characterization," said Kenneth Simpson, professor of small animal medicine at the College of Veterinary Medicine. "Our findings raise the possibility that a novel group of E. coli contains opportunistic pathogens that may be causally related to chronic intestinal inflammation in susceptible individuals. They suggest that an integrated approach that considers an individual's mucosa-associated flora in addition to disease phenotype and genotype may improve outcome."
The study found an increased level of E. coli bacteria in more inflamed areas of the small intestines instead of MAP, a bacterium related to tubercle bacillus that has been more commonly associated with Crohn's.
###
To access the full research study titled "Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum" and related microscopic images, access the current issue of the ISME Journal at http://www.nature.com/ismej/journal/vaop/ncurrent/abs/ismej200752a.html.
The study was supported by an Ithaca Cornell-Weill Cornell Seed Grant.
Source: Sabina Lee
Cornell University News Service
Visit our gastrointestinal / gastroenterology section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/79093.php>
APA
http://www.medicalnewstoday.com/releases/79093.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





